Integrated Diagnostics Inc. aims to deliver on the long-heralded promise of personalized medicine with simple blood tests capable of diagnosing disease and spotlighting problems even before a patient notices signs of clinical disease. These new tests might also help physicians determine which type of drug is best suited for a particular patient, and monitor patients' response to treatment.
1441 North 34th Street
Seattle, WA 98103
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.
Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.
European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.
